Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax

被引：9

作者：

Candoni, Anna ^{[1
]}

Lazzarotto, Davide ^{[2
]}

Papayannidis, Cristina ^{[3
]}

Piccini, Matteo ^{[4
]}

Nadali, Giampaolo ^{[5
]}

Dargenio, Michelina ^{[6
]}

Riva, Marta ^{[7
]}

Fracchiolla, Nicola ^{[8
]}

Mellillo, Lorella ^{[9
]}

Dragonetti, Giulia ^{[10
]}

Del Principe, Maria Ilaria ^{[11
]}

Cattaneo, Chiara ^{[12
]}

Stulle, Manuela ^{[13
]}

Pasciolla, Crescenza ^{[14
]}

De Marchi, Roberta ^{[15
]}

Delia, Mario ^{[16
]}

Tisi, Maria Chiara ^{[17
]}

Bonuomo, Valentina ^{[5
]}

Sciume, Mariarita ^{[7
]}

Spadea, Antonio ^{[18
]}

Sartor, Chiara ^{[3
]}

Griguolo, Davide ^{[13
]}

Buzzatti, Elisa ^{[11
]}

Basilico, Claudia Maria ^{[19
]}

Sarlo, Chiara ^{[20
]}

Piccioni, Anna Lina ^{[21
]}

Cerqui, Elisa ^{[12
]}

Lessi, Federica ^{[22
]}

Olivieri, Attilio ^{[23
]}

Fanin, Renato ^{[2
]}

Luppi, Mario ^{[1
]}

Pagano, Livio ^{[10
]}

机构：

[1] Univ Modena & Reggio Emilia, Azienda Osped Univ Modena, Dept Med & Surg Sci, Sect Hematol, Modena, Italy

[2] Univ Udine, Div Hematol & Stem Cell Transplantat, ASUFC, Udine, Italy

[3] Univ Bologna, Inst Hematol & Med Oncol L&A Seragnoli, Bologna, Italy

[4] Azienda Osped Univ Careggi, Div Hematol, Florence, Italy

[5] Policlin GB Rossi, Div Hematol, AOUI, Verona, Italy

[6] Osped Vito Fazzi, Div Hematol, Lecc, Italy

[7] ASST Grande Osped Metropolitano, Dipartimento Ematol Oncol, Niguarda Canc Ctr, Milan, Italy

[8] Univ Milan, Fdn IRCCS CaGranda Osped Maggiore Policlin, UO Oncoematol, Milan, Italy

[9] Foggia & IRCCS Casa Sollievo Sofferenza, Div Hematol, San Giovanni Rotondo, Italy

[10] Univ Cattolica Sacro Cuore, Fdn Policlin A Gemelli IRCCS, Div Hematol, Polo Onco Ematol, Rome, Italy

[11] Fdn Policlin Tor Vergata, Hematol, Rome, Italy

[12] Spedali Civil Brescia, Sect Hematol, Brescia, Italy

[13] ASUGI, Div Hematol, Trieste, Italy

[14] IRCCS Ist Tumori Giovanni Paolo II, Haematol Unit, Bari, Italy

[15] IRCCS, Veneto Inst Oncol IOV, Dept Oncol, Onco Hematol, Padua, Italy

[16] Univ Bari, Hematol & Bone Marrow Transplantat Unit, Azienda Osped Univ Consorziale Policlin, Bari, Italy

[17] Univ Milan, San Bortolo Hosp Vicenza, Fdn IRCCS CaGranda Osped Maggiore Policlin, Cell Therapy & Hematol,7UO Oncoematol, Milan, Italy

[18] IRCCS Regina Elena Natl Canc Inst, Hematol & Stem Cell Transplant Unit, Rome, Italy

[19] Osped Circolo & Fdn Macchi, Div Hematol, ASST Sette Laghi, Varese, Italy

[20] Univ Campus Biomed, Hematol & Stem Cell Transplantat Unit, Rome, Italy

[21] Azienda Osped San Giovanni Addolorata, Dipartimento Ematol, Rome, Italy

[22] Azienda Osped Univ Padova, Dept Med, Hematol Unit, DIMED, Padua, Italy

[23] Azienda Osped Univ Osped Riuniti Ancona, Div Hematol, Ancona, Italy

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 04期

关键词：

D O I：

10.1002/ajh.26846

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E80 / E83

页数：4

共 6 条

[1] Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents
Aldoss, Ibrahim
Dadwal, Sanjeet
Zhang, Jianying
Tegtmeier, Bernard
Mei, Matthew
Arslan, Shukaib
Al Malki, Monzr M.
Salhotra, Amandeep
Ali, Haris
Aribi, Ahmed
Sandhu, Karamjeet
Khaled, Samer
Snyder, David
Nakamura, Ryotaro
Stein, Anthony S.
Forman, Stephen J.
Marcucci, Guido
Pullarkat, Vinod
[J]. BLOOD ADVANCES, 2019, 3 (23) : 4043 - 4049
[2] Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
DiNardo, C. D.
Jonas, B. A.
Pullarkat, V.
Thirman, M. J.
Garcia, J. S.
Wei, A. H.
Konopleva, M.
Doehner, H.
Letai, A.
Fenaux, P.
Koller, E.
Havelange, V.
Leber, B.
Esteve, J.
Wang, J.
Pejsa, V.
Hajek, R.
Porkka, K.
Illes, A.
Lavie, D.
Lemoli, R. M.
Yamamoto, K.
Yoon, S. -S.
Jang, J. -H.
Yeh, S. -P.
Turgut, M.
Hong, W. -J.
Zhou, Y.
Potluri, J.
Pratz, K. W.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07) : 617 - 629
[3] How I treat acute myeloid leukemia in the era of new drugs
DiNardo, Courtney D.
Wei, Andrew H.
[J]. BLOOD, 2020, 135 (02) : 85 - 96
[4] Infections of Venetoclax-Based Chemotherapy in Acute Myeloid Leukemia: Rationale for Proper Antimicrobial Prophylaxis
Lee, Raeseok
Cho, Sung-Yeon
Lee, Dong-Gun
Choi, Hyeah
Park, Silvia
Cho, Byung-Sik
Kim, Yoo-Jin
Kim, Hee-Je
[J]. CANCERS, 2021, 13 (24)
[5] Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent
On, Sandy
Rath, Carolyn G.
Lan, Michelle
Wu, Bobby
Lau, Kimberly M.
Cheung, Edna
Alegria, William
Young, Rebecca
Tan, Marisela
Kim, Carrie
Phun, Jennifer
Patel, Nimish
Mannis, Gabriel
Logan, Aaron C.
Kennedy, Vanessa
Goodman, Aaron
Taplitz, Randy A.
Young, Patricia A.
Wen, Raymond
Saunders, Ila M.
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (01) : 63 - 70
[6] Acute Myeloid Leukemia, Version 2.2021 Featured Updates to the NCCN Guidelines
Pollyea, Daniel A.
Bixby, Dale
Perl, Alexander
Bhatt, Vijaya Raj
Altman, Jessica K.
Appelbaum, Frederick R.
de Lima, Marcos
Fathi, Amir T.
Foran, James M.
Gojo, Ivana
Hall, Aric C.
Jacoby, Meagan
Lancet, Jeffrey
Mannis, Gabriel
Marcucci, Guido
Martin, Michael G.
Mims, Alice
Neff, Jadee
Nejati, Reza
Olin, Rebecca
Percival, Mary-Elizabeth
Prebet, Thomas
Przespolewski, Amanda
Rao, Dinesh
Ravandi-Kashani, Farhad
Shami, Paul J.
Stone, Richard M.
Strickland, Stephen A.
Sweet, Kendra
Vachhani, Pankit
Wieduwilt, Matthew
Gregory, Kristina M.
Ogba, Ndiya
Tallman, Martin S.
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (01): : 17 - 27

← 1 →